Navigation Links
K-V Pharmaceutical Company States That Its Policy is Not to Comment on Unusual Market Activity
Date:5/25/2012

ST. LOUIS, May 25, 2012 /PRNewswire/ -- K-V Pharmaceutical Company (the "Company") (NYSE: KVa/KVb) today announced that in view of the unusual market activity in the Company's common stock, the NYSE has contacted the Company in accordance with its usual practice. K-V's policy is not to comment on unusual market activity.

About K-V Pharmaceutical Company

K-V Pharmaceutical Company is a specialty branded pharmaceutical company with a primary focus in the area of women's healthcare.   As such, we are committed to advancing the health of women across all the stages of their lives.

For further information about K-V Pharmaceutical Company, please visit the Company's corporate Website at www.kvpharmaceutical.com.

Cautionary Note Regarding Forward-looking Statements

This press release contains various forward-looking statements within the meaning of the United States Private Securities Litigation Reform Act of 1995 (the "PSLRA") and which may be based on or include assumptions concerning our operations, future results and prospects. Such statements may be identified by the use of words like "plan," "expect," "aim," "believe," "project," "anticipate," "commit," "intend," "estimate," "will," "should," "could," "potential" and other expressions that indicate future events and trends.

All statements that address expectations or projections about the future, including, without limitation, statements about product launches, governmental and regulatory actions and proceedings, market position, revenues, expenditures and the impact of the recall and suspension of shipments on revenues, and other financial results, are forward-looking statements.

All forward-looking statements are based on current expectations and are subject to risk and uncertainties. In connection with the PSLRA's "safe harbor" provisions, we provide the following cautionary stat
'/>"/>

SOURCE K-V Pharmaceutical Company
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6

Related medicine technology :

1. Thomson Scientific Publishes The Ones to Watch - A Quarterly Review of Phase Changes in the Pharmaceutical Pipeline
2. Auxilium Pharmaceuticals, Inc. Receives Clearance to Resume Clinical Trials for XIAFLEX(TM)
3. Vion Pharmaceuticals Completes Accrual of 85 Patients to its Pivotal Phase II Trial of Cloretazine(R) (VNP40101M) in Elderly AML
4. Solvay Pharmaceuticals, Inc. and Wyeth Pharmaceuticals Announce Receipt of an FDA Action Letter for Bifeprunox, an Investigational Treatment for Schizophrenia
5. DOV Pharmaceutical, Inc. Announces Successful Phase Ib Results for DOV 21,947
6. Callisto Pharmaceuticals Opens Additional Sites for Phase II Clinical Trial of Atiprimod in Advanced Carcinoid Cancer Patients
7. WallSt.net (www.wallst.net) Updates the Investment Community Through an All-New Interview With RegeneRx Biopharmaceuticals CEO
8. Par Pharmaceutical Begins Shipment of Additional Dosage Strength of Generic TOPROL-XL(R)
9. Quark Pharmaceuticals, Inc. Presented Positive Preclinical Results of Systemic RNAi Compound for Acute Renal Failure (ARF)
10. Peregrine Pharmaceuticals Doses First Patient in Cotara(R) Phase II Brain Cancer Trial In India
11. Nabi Biopharmaceuticals Announces Second Quarter 2007 Financial Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/2/2015)... VANCOUVER , July 2, 2015 /PRNewswire/ - ... today that its common shares have been approved for listing ... symbol "EPIX". ESSA will begin trading on NASDAQ ... on the TSX Venture Exchange under the symbol "EPI". ... shares on the NASDAQ, each of the Company,s outstanding special ...
(Date:7/2/2015)... LAUDERDALE, Fla. , July 2, 2015 /PRNewswire/ ... Co., is pleased to announce that its Consumer ... ("Insight Beverages") to Kerry Group plc (ISE: KRZ) ... on taste and nutrition systems, as well as ... beverage and pharmaceutical markets. Farlie Turner served as ...
(Date:7/2/2015)... YORK , July 2, 2015 ... a conspicuously high-growth market segment in hematology testing, ... publisher said that Roche,s recent unveiling of its Bloodhound ... the cobas m 511 hematology analyzer ... only capture growth enjoyed by current leader CellaVision, ...
Breaking Medicine Technology:ESSA Pharma Inc. to Commence Trading on the NASDAQ Capital Market 2ESSA Pharma Inc. to Commence Trading on the NASDAQ Capital Market 3ESSA Pharma Inc. to Commence Trading on the NASDAQ Capital Market 4Farlie Turner's Consumer Group Completes Sale of Insight Beverages to Kerry 2Kalorama: With Bloodhound, Roche Closes in on High-Growth Hematology Segment 2Kalorama: With Bloodhound, Roche Closes in on High-Growth Hematology Segment 3
(Date:7/3/2015)... ... July 03, 2015 , ... Yisrayl Hawkins, Pastor and Overseer at ... that he says will reveal biblical truth and expose popular lies regarding proper relationships ... Say Don’t Have Sex”, immediately goes into the core of the subject by explaining ...
(Date:7/3/2015)... (PRWEB) , ... July 03, 2015 , ... The Celebrity ... or cocktail dresses similar to those of celebrities will have the opportunity to get ... at checkout. This ensures that people do not have to use coupon codes or ...
(Date:7/2/2015)... ... 02, 2015 , ... sweetFrog Enterprises, LLC. is pleased to announce the opening of its newest ... Lone Star State. The premium frozen yogurt chain was listed as #22 on the Inc. ... in the Village at Bachman Lake, is located at:, 3701 W. Northwest Highway, STE 430, ...
(Date:7/2/2015)... ... July 02, 2015 , ... Following the recent report by ... of obese Americans outnumber merely overweight Americans, Samir Becic emphatically declared a war on ... American society right now," Becic said. "We must understand the magnitude of this discovery. ...
(Date:7/2/2015)... WIsconsin (PRWEB) , ... July 02, 2015 , ... ... for the parking structure retrofit project at the University of Minnesota, they knew ... is that it would also be an award-winning choice: the total energy savings ...
Breaking Medicine News(10 mins):Health News:Yisrayl Hawkins Explains What the Bible Really Says about Sex in New Publication This Week 2Health News:Celebrity Fashion Summer Party Dresses on sale at TheCelebrityDresses.com 2Health News:sweetFrog Opens 18th Location in the Lone Star State 2Health News:Samir Becic's Health Fitness Revolution Declares War Against Obesity in America 2Health News:Samir Becic's Health Fitness Revolution Declares War Against Obesity in America 3Health News:Samir Becic's Health Fitness Revolution Declares War Against Obesity in America 4Health News:Kenall’s TekDek™ Helps University Achieve Award-Winning Energy Savings in Parking Structure Lighting Retrofit 2
... , HOPKINTON, Mass., Sept. ... the world leader in information infrastructure solutions, today announced ... with more than 25,000 healthcare provider customers, has consolidated ... RSA and VMware solutions. As a result, eClinicalWorks ...
... , WESTON, Fla., Sept. 14 ... Sheets: ASFX) (the Company), is excited to announce that it ... approved home needle destruction device (NDD), the Disintegrator(TM) and Disintegrator ... (the "Device Technology"). , , A ...
... lower screening rates, researchers say , MONDAY, Sept. 14 ... screening rates for colorectal cancer among Mexican-Americans, a San ... survey of close to 17,000 older Californian residents found ... another person to help them talk with doctors -- ...
... , CHERRY HILL, N.J., Sept. 14 ... results from the Company,s ongoing sponsored research studies indicate that ... species of turfgrass. In the coming months Nuvilex intends to ... States under conditions that are most optimal for turfgrass growth. ...
... , , LOS ANGELES, ... season continued with the Avon Walk in Los Angeles this weekend, ... and finding a cure for breast cancer. The Avon Walk Los ... the event attracted more than 2,000 participants drawn from 33 states, ...
... Sept. 14 /PRNewswire-FirstCall/ - HTDS www.htdsmedical.com The ... its shareholders and followers on the (H1N1) Vaccine for ... general business matters. , At the beginning of September, ... (H1N1) Vaccine (Split Virion). The company received the clinical ...
Cached Medicine News:Health News:eClinicalWorks Utilizes EMC to Manage Business Expansion and Reduce Costs 2Health News:eClinicalWorks Utilizes EMC to Manage Business Expansion and Reduce Costs 3Health News:American Scientific Resources Acquires Intellectual Property to World's Only FDA Approved Home Needle Destruction Device 2Health News:American Scientific Resources Acquires Intellectual Property to World's Only FDA Approved Home Needle Destruction Device 3Health News:Too Few Latinos Get Colorectal Cancer Tests 2Health News:Nuvilex, Inc. Announces Positive Oraphyte(TM) Microplot Results 2Health News:Nuvilex, Inc. Announces Positive Oraphyte(TM) Microplot Results 3Health News:Nuvilex, Inc. Announces Positive Oraphyte(TM) Microplot Results 4Health News:Video: Seventh Annual Avon Walk for Breast Cancer Los Angeles Raises More Than $4.6 Million 2Health News:Video: Seventh Annual Avon Walk for Breast Cancer Los Angeles Raises More Than $4.6 Million 3Health News:Video: Seventh Annual Avon Walk for Breast Cancer Los Angeles Raises More Than $4.6 Million 4Health News:Video: Seventh Annual Avon Walk for Breast Cancer Los Angeles Raises More Than $4.6 Million 5Health News:Hard To Treat Diseases (HTDS) (H1N1) Vaccine Clinical Approval and Production 2Health News:Hard To Treat Diseases (HTDS) (H1N1) Vaccine Clinical Approval and Production 3Health News:Hard To Treat Diseases (HTDS) (H1N1) Vaccine Clinical Approval and Production 4
... save inventory, shelf space, and resources, Quadra-Coil ... 22 cm to 28 cm. An advanced ... over any guidewire and through the most ... placement and patient comfort in a multi-length ...
... Used for temporary internal drainage ... bladder. Supplied sterile in peel-open packages. ... evaluation is advised; C-Flex® and Sof-Flex® ... than six (6) months; silicone stents ...
... for temporary internal drainage from the ... sterile in peel-open packages. Intended for ... advised; C-Flex® and Sof-Flex® stents must ... (6) months; silicone stents must not ...
... Ureteral Stents have an exclusive balanced-curled ... They also feature unique Tecoflex construction ... Each Classic Double PigTail Ureteral ... PigTail Ureteral Stent with attached braided ...
Medicine Products: